Corteva, Inc. Q2 2026 Earnings Recap

Corteva’s shares fell 11.9% post-earnings as the cautious outlook and signs of margin pressure outweighed solid first-half execution, disappointing investors despite raised full-year guidance.

Key Takeaways

• First half net sales rose 4%, operating EBITDA increased 10%, and operating EPS grew 14%, reflecting steady execution across seed and crop protection.
• Pricing in crop protection was essentially flat amid competitive market conditions, indicating limited pricing power and potential margin headwinds.
• Management highlighted ongoing pricing pressure in certain crop protection segments and farmer caution on discretionary spending, signaling deceleration risks.
• Raised full-year guidance to $4.1-$4.3 billion EBITDA and $3.60-$3.80 EPS, factoring in productivity gains and licensing growth, but tempered by a “healthy respect” for market risks.
• Separation from Dow Inc. remains on schedule and on budget, with progress on leadership and organizational milestones offsetting separation-related expenses.